Development of pharmacotherapies for abdominal aortic aneurysms.

Biomed Pharmacother · 2022 · PMC9514980 · PMID 35780618

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

While the difference between AAA size of the above treatment groups may be significant, it is not necessarily clinically relevant.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.